A private equity fund operator, ‘H&Q,’ takes over Ildong Pharmaceutical’s shares owned by Green Cross
H&Q Korea, a domestic private equity fund operator, will become the 2nd largest shareholder of Ildong Pharmaceutical as purchasing closely 25% of its shares owned by Green Cross, the former 2nd largest shareholder.
On the 24th, the Korea Economic Daily reported a confirmation that the Ildong Pha...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
